Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CSLLY CSL LTD SPON ADR EACH REPR 0.5 ORD

92.535
+2.025+2.24%
Trading Session 09/26 12:18 ET
High
93.650
Open
91.000
Turnover
4.63M
Low
91.000
Pre Close
90.510
Volume
49.88K
Market Cap
89.24B
P/E(TTM)
38.56
52wk High
116.033
Shares
964.43M
P/E(Static)
38.56
52wk Low
84.052
Float Cap
89.24B
Bid/Ask %
0.00%
Historical High
116.033
Shs Float
964.43M
Volume Ratio
2.05
Historical Low
84.052
Dividend TTM
1.11
Div Yield TTM
--
P/B
6.12
Dividend LFY
1.20%
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
2.93%
Avg Price
92.828
Lot Size
1
Float Cap
89.24B
Bid/Ask %
0.00%
Historical High
116.033
Shs Float
964.43M
Volume Ratio
2.05
Historical Low
84.052
Dividend TTM
1.11
P/B
6.12
Dividend LFY
1.20%
Turnover Ratio
0.01%
Amplitude
2.93%
Avg Price
92.828
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring and CSL Seqirus. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The CSL Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.
CEO: Mr. Paul Perreault
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...